Microperimetry and Optical Coherence Tomography (OCT) in Idiopathic Epiretinal Membrane
NCT ID: NCT01481987
Last Updated: 2011-11-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
76 participants
INTERVENTIONAL
2011-01-31
2011-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Design: Cross sectional case-control series.
Methods:
Setting: Dijon University Hospital. Patients: Forty nine patients (49 eyes) with idiopathic ERM and twenty-seven healthy patients (27 eyes) as a control group.
Main outcome measurement: Microperimetry, Spectral Domain Optical Coherence Tomography (SD-OCT).
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Epiretinal Membrane
The investigators prospectively included 49 eyes of 49 patients with idiopathic ERM for which surgical treatment had been planned.
Epiretinal Membrane Surgical treatment
epiretinal membrane peeling
Control
Subjects with normal visual acuity and OCT profile
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Epiretinal Membrane Surgical treatment
epiretinal membrane peeling
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Diabetic macular edema
18 Years
90 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire Dijon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nicot Frederic
Head of research unit in Ophthalmology department
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Catherine Creuzot-Garcher, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
CHU Dijon
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ophthalmology Department CHU Dijon
Dijon, Burgundy, France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Rodica 01
Identifier Type: -
Identifier Source: org_study_id